By Philip van Doorn, MarketWatch
There’s no question that third-quarter earnings season has been pretty bad. But there are always companies that outperform, and we have listed a group of sales-growth winners below.
First, the bad news
Through Monday, 97% of the S&P 500 (S&P:SPX) had reported results for fiscal quarters ended July 26 or later. According to the most recent Consensus Snapshot report from S&P Global Market Intelligence, combined and weighted earnings per share (EPS) for the S&P 500 were down an estimated 4.1% from a year earlier — which was even worse than the estimate of a 3.3% decline a month ago.
That runs counter to the usual trend among sell-side analysts of setting up earnings “beats” by incorporating lowered guidance from the companies they monitor into earnings (and sales) estimates that are, arguably, too low. Then again, according to S&P Global, 86% of the reporting companies have beaten consensus earnings estimates, 62% have beaten sales estimates and 57% have beaten both.
Here’s a summary of the most recent estimates for changes in third-quarter earnings per share from a year earlier:
|S&P 500 sector||Estimated change in EPS|
|S&P 500 Index||-4.11%|
|Source: S&P Global Market Intelligence|
That’s a lackluster quarter, reflecting a less-than-favorable market for commodity and energy prices, as well as the effect of the trade conflict between the U.S. and China on the technology sector. Semiconductor manufacturers were hit particularly hard.
However, investors have been hopeful of an easing of trade tensions, or at least a resumption of sales growth for the semiconductor group next year from 2019’s lower base. The iShares PHLX Semiconductor ETF (NAS:SOXX) , which holds all 30 stocks in the PHLX Semiconductor index, has risen 52% year-to-date.
Sales and margin winners
Any company will wish to increase its revenue, but it will also try to improve its gross margin, which is its sales, less the cost of goods sold, divided by sales. It is a measure of a company’s pricing power. An expanding margin as sales rise is a very good sign. A narrowing margin may indicate the company is being forced to defend its market share with discounts or is pushing sales growth over profitability. If the margin continues to narrow, the company may be facing a very difficult market for its products or services.
Gross margin isn’t used by analysts who track banks and insurance companies.
Among the S&P 500 companies that had announced results for fiscal quarters ended July 26 or later through Nov. 12, here are the 20 that reported the largest increases in sales, while also expanding their gross margins:
|Company||Ticker||Industry||Sales growth - most recent quarter from a year earlier||Change in sales per share - most recent quarter from year-earlier quarter||Gross margin - most recent quarter||Gross margin - year-earlier quarter|
|Fiserv Inc.||(NAS:FISV)||Data Processing Services||122%||53%||48.31%||45.33%|
|Newmont Goldcorp Corp.||(NYS:NEM)||Precious Metals||56%||2%||22.85%||20.81%|
|Prologis Inc.||(NYS:PLD)||Real-estate investment Trusts||38%||26%||44.12%||36.22%|
|CVS Health Corp.||(NYS:CVS)||Drugstore Chains||36%||7%||17.78%||15.90%|
|Fidelity National Information Services Inc.||(NYS:FIS)||Data Processing Services||35%||-14%||34.87%||34.55%|
|Marathon Petroleum Corp.||(NYS:MPC)||Oil Refining/Marketing||35%||-7%||8.84%||7.84%|
|Netflix Inc.||(NAS:NFLX)||Cable/Satellite TV||31%||31%||40.93%||39.68%|
|MarketAxess Holdings Inc.||(NAS:MKTX)||Investment Banks/Brokers||28%||27%||87.19%||86.60%|
|Alexion Pharmaceuticals Inc.||(NAS:ALXN)||Biotechnology||23%||24%||85.14%||83.33%|
|NextEra Energy Inc.||(NYS:NEE)||Electric Utilities||23%||8%||34.52%||28.29%|
|Intuitive Surgical Inc.||(NAS:ISRG)||Medical Specialties||23%||22%||69.63%||69.53%|
|Dominion Energy Inc.||(NYS:D)||Electric Utilities||22%||-2%||61.86%||61.40%|
|CenterPoint Energy Inc.||(NYS:CNP)||Electric Utilities||21%||4%||16.27%||14.24%|
|Copart Inc.||(NAS:CPRT)||Mis. Commercial Services||21%||24%||43.65%||40.91%|
|Fortinet Inc.||(NAS:FTNT)||Computer Communications||21%||21%||71.16%||70.15%|
|Vertex Pharmaceuticals Inc.||(NAS:VRTX)||Biotechnology||20%||20%||85.96%||85.79%|
|PayPal Holdings Inc.||(NAS:PYPL)||Data Processing Services||19%||20%||44.47%||39.77%|
You can click on the tickers for more about each company.
Changes in sales per share are also shown because they can provide more insight. The increase in sales per share will be less than the increase in sales if a company’s share count has increased. Small increases in the share count probably reflect the exercise of stock-based awards to executives.
A company’s sales may rise considerably following an acquisition, but if the company has issued new shares to help pay for the purchase, the shares may be diluted considerably, which means the buyer’s shareholders have had their percentage of ownership meaningfully reduced. The per-share numbers show how much their portion of sales increased. That helps investors understand if an acquisition was worthwhile for them.
Fiserv’s (NAS:FISV) third-quarter revenue more than doubled from a year earlier, reflecting its $22 billion all-stock acquisition of First Data Corp. on July 29. The company’s third-quarter results were consolidated for the full quarter, and First Data contributed 51% of sales.
If a company issues enough shares, you might even see sales per share declining as raw revenue increased. This may not necessarily indicate a problem if it fits in with a successful long-term growth strategy. But if the per-share number is significantly different from the raw number, you had better learn why if you are considering a stock for investment.
Ratings and price targets
Here’s a summary of sell-side analysts’ opinions of these companies:
|Company||Ticker||Share 'buy' ratings||Share neutral ratings||Share 'sell' ratings||Closing price - Nov. 11||Consensus price target||Implied 12-month upside potential|
|Newmont Goldcorp Corp.||(NYS:NEM)||67%||33%||0%||$36.71||$47.52||29%|
|CVS Health Corp.||(NYS:CVS)||70%||30%||0%||$71.73||$77.08||7%|
|Fidelity National Information Services Inc.||(NYS:FIS)||79%||17%||4%||$132.36||$154.65||17%|
|Marathon Petroleum Corp.||(NYS:MPC)||94%||6%||0%||$65.71||$80.35||22%|
|MarketAxess Holdings Inc.||(NAS:MKTX)||0%||82%||18%||$359.74||$325.00||-10%|
|Alexion Pharmaceuticals Inc.||(NAS:ALXN)||83%||17%||0%||$109.01||$151.10||39%|
|NextEra Energy Inc.||(NYS:NEE)||88%||6%||6%||$222.22||$243.43||10%|
|Intuitive Surgical Inc.||(NAS:ISRG)||71%||23%||6%||$544.80||$607.87||12%|
|Dominion Energy Inc||(NYS:D)||31%||69%||0%||$79.62||$84.82||7%|
|CenterPoint Energy Inc.||(NYS:CNP)||65%||35%||0%||$27.70||$31.83||15%|
|Vertex Pharmaceuticals Inc.||(NAS:VRTX)||73%||27%||0%||$201.90||$228.33||13%|
|PayPal Holdings Inc||(NAS:PYPL)||76%||24%||0%||$102.67||$125.87||23%|
<STRONG>Create an email alert for Philip van Doorn’s Deep Dive columns <INTERNAL-PAGE URL="/tools/alerts/newsColumn.asp">here</INTERNAL-PAGE>.</STRONG>